Onward Medical NV ONWD

BRU: ONWD | ISIN: NL0015000HT4   4/11/2025
4,020 EUR (-1,47%)
(-1,47%)   4/11/2025

28 oktober 2025 · ONWARD Medical Publishes Closing of Bookbuild Offering · Persbericht

24 oktober 2025 · ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase · Persbericht

22 oktober 2025 · ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million · Persbericht

13 oktober 2025 · ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States · Persbericht

8 oktober 2025 · Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20 · Persbericht

8 oktober 2025 · Portzamparc – Groupe BNP Paribas initie la couverture d’ONWARD Medical avec une recommandation d’Achat et un objectif de cours de 10,20 EUR · Persbericht

18 september 2025 · Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy · Persbericht

8 september 2025 · ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe · Persbericht

2 september 2025 · ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025 · Persbericht

18 augustus 2025 · ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System · Persbericht

6 augustus 2025 · ONWARD Medical annonce la nomination de Lucas Buchanan à son conseil d’administration · Persbericht

6 augustus 2025 · ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors · Persbericht

7 juli 2025 · ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors · Persbericht

1 juli 2025 · ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application · Persbericht

17 juni 2025 · ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025 · Persbericht

11 juni 2025 · ONWARD Medical Announces Results of its Annual General Meeting of Shareholders · Persbericht

11 juni 2025 · ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights · Persbericht

21 mei 2025 · ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants · Persbericht

30 april 2025 · ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions · Persbericht

28 april 2025 · ONWARD Medical Announces Release of 2024 Annual Report · Persbericht

Mijn selecties